Tideglusib
Tideglusib is a small molecule drug that has been investigated for its potential therapeutic effects in various medical conditions, including Alzheimer's disease and autism spectrum disorder. It functions primarily as an inhibitor of glycogen synthase kinase 3 (GSK-3), an enzyme involved in numerous cellular processes.
Mechanism of Action[edit]
Tideglusib inhibits the activity of glycogen synthase kinase 3 (GSK-3), which plays a crucial role in the regulation of various cellular functions, including glycogen metabolism, cell proliferation, and apoptosis. By inhibiting GSK-3, Tideglusib can modulate these processes, potentially leading to therapeutic benefits in diseases characterized by dysregulated GSK-3 activity.
Therapeutic Applications[edit]
Alzheimer's Disease[edit]
Tideglusib has been studied for its potential to treat Alzheimer's disease, a neurodegenerative disorder characterized by the accumulation of beta-amyloid plaques and neurofibrillary tangles in the brain. By inhibiting GSK-3, Tideglusib may reduce the formation of these pathological features and improve cognitive function.
Autism Spectrum Disorder[edit]
Research has also explored the use of Tideglusib in treating autism spectrum disorder (ASD). GSK-3 is involved in the regulation of synaptic plasticity and neurodevelopment, processes that are often disrupted in ASD. Tideglusib's inhibition of GSK-3 may help to normalize these processes and alleviate some symptoms of ASD.
Other Potential Uses[edit]
Tideglusib has been investigated for its potential in treating other conditions, such as progressive supranuclear palsy and myotonic dystrophy. Its broad mechanism of action suggests that it may have therapeutic effects in a variety of diseases involving dysregulated GSK-3 activity.
Clinical Trials[edit]
Several clinical trials have been conducted to evaluate the safety and efficacy of Tideglusib in different patient populations. While some studies have shown promising results, others have not demonstrated significant benefits, highlighting the need for further research to fully understand its therapeutic potential.
Side Effects[edit]
Common side effects of Tideglusib include nausea, fatigue, and headache. More serious adverse effects are rare but may include liver toxicity and cardiac arrhythmias. Patients undergoing treatment with Tideglusib should be monitored for these potential side effects.
Related Pages[edit]
- Alzheimer's disease
- Autism spectrum disorder
- Glycogen synthase kinase 3
- Neurodegenerative disease
- Synaptic plasticity
References[edit]
External Links[edit]
-
| Tideglusib | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
